Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Alistair Campbell is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/12/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/15/2024 | GMAB | Buy Now | Genmab | $26.17 | — | — | Upgrade | Sector Perform → Outperform | Get Alert |
| 10/31/2023 | ABCM | Buy Now | Abcam | — | — | $25 → $24 | Maintains | Sector Perform | Get Alert |
| 10/09/2023 | ABCM | Buy Now | Abcam | — | — | → $25 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 08/22/2023 | ABCM | Buy Now | Abcam | — | — | → $25 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 06/20/2023 | ABCM | Buy Now | Abcam | — | — | $23 → $22 | Downgrade | Outperform → Sector Perform | Get Alert |
| 04/28/2023 | ABCM | Buy Now | Abcam | — | — | $21.5 → $23 | Maintains | Outperform | Get Alert |
| 01/25/2022 | NVO | Buy Now | Novo Nordisk | $141.68 | — | — | Downgrade | Hold → Sell | Get Alert |
